The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Gubanova M.V.

Research Center of Neurology

Kalashnikova L.A.

Research Center of Neurology

Dobrynina L.A.

Research Center of Neurology

Fibromuscular dysplasia and its neurological manifestations

Authors:

Gubanova M.V., Kalashnikova L.A., Dobrynina L.A.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(11): 116‑123

DOI: 10.17116/jnevro2020120111116

Read: 9787 times

Download PDF (RU)
Contact the author
Table of contents

FIBROMUSCULAR DYSPLASIA AND ITS NEUROLOGICAL MANIFESTATIONS
FIBROMUSCULAR DYSPLASIA AND ITS NEUROLOGICAL MANIFESTATIONS

To cite this article:

Gubanova MV, Kalashnikova LA, Dobrynina LA. Fibromuscular dysplasia and its neurological manifestations. S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(11):116‑123. (In Russ.)
https://doi.org/10.17116/jnevro2020120111116

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

The authors present the current data on the classification, epidemiology, etiology, neurological manifestations, prognosis, diagnosis, and treatment of patients with fibromuscular dysplasia (FMD). The review is based on the selection of publications by searching PubMed for keywords from the first sources until March 2019. FMD is a segmental non-atherosclerotic and non-inflammatory disease of large- and medium-caliber arteries leading to their stenosis. The disease occurs mostly in women (90%), and manifests itself in the 5th decade of life. In the cerebrovascular form of FMD, the extracranial internal carotid artery and the vertebral artery are usually affected. Diagnosis is based on the identification of alternation of narrowing and dilation of arteries using angiography (the string of beads sign (multifocal form)). Neurological manifestations include headache, tinnitus, and ischemic stroke, usually due to the dissection or stenosis, rarely, intracerebral or subarachnoid hemorrhages. The prognosis in most cases is favorable, relapses of strokes are rare. Treatment includes antiplatelet agents, if they are ineffective to prevent recurrence of ischemic stroke, endovascular treatment is carried out. Approaches to the treatment of intracranial aneurysms do not differ from those in patients without FMD.

Keywords:

fibromuscular dysplasia
cerebrovascular form
cervical artery dissection
aneurysm
ischemic stroke
headache

Authors:

Gubanova M.V.

Research Center of Neurology

Kalashnikova L.A.

Research Center of Neurology

Dobrynina L.A.

Research Center of Neurology

Received:

06.04.2020

Accepted:

17.04.2020

Close metadata

References:

  1. Touzé E, Southerland AM, Boulanger M, Labeyrie PE, Azizi M, Bouatia-Naji N, Debette S, Gornik HL, Hussain SM, Jeunemaitre X, Joux J, Kirton A, Le Hello C, Majersik JJ, Mocco J, Persu A, Sharma A, Worrall BB, Olin JW, Plouin PF. Fibromuscular dysplasia and its neurologic manifestations: a systematic review. JAMA Neurology. 2019;76(2):217-226.  https://doi.org/10.1001/jamaneurol.2018.2848
  2. Gornik HL, Persu A, Adlam D, Aparicio LS, Azizi M, Boulanger M, Bruno RM, de Leeuw P, Fendrikova-Mahlay N, Froehlich J, Ganesh SK, Gray BH, Jamison C, Januszewicz A, Jeunemaitre X, Kadian-Dodov D, Kim ES, Kovacic JC, Mace P, Morganti A, Sharma A, Southerland AM, Touzé E, van der Niepen P, Wang J, Weinberg I, Wilson S, Olin JW, Plouin PF. First International Consensus on the diagnosis and management of fibromuscular dysplasia. Vascular Medicine. 2019;24(2):164-189.  https://doi.org/10.1177/1358863X18821816
  3. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CG, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees AJ, Scott DG, Specks U, Stone JH, Takahashi K, Watts RA. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65(1):1-11.  https://doi.org/10.1002/art.37715
  4. Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, Lindley RI, O’Brien JT, Barkhof F, Benavente OR, Black SE, Brayne C, Breteler M, Chabriat H, Decarli C, de Leeuw FE, Doubal F, Duering M, Fox NC, Greenberg S, Hachinski V, Kilimann I, Mok V, Oostenbrugge RV, Pantoni L, Speck O, Stephan BC, Teipel S, Viswanathan A, Werring D, Chen C, Smith C, van Buchem M, Norrving B, Gorelick PB, Dichgans M; Standards for Reporting Vascular changes on neuroimaging (STRIVE v1). Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12(8):822-838.  https://doi.org/10.1016/S1474-4422(13)70124-8
  5. Leadbetter WF, Burkland CE. Hypertension in unilateral renal disease. J Urol. 1938;39(5):611-626.  https://doi.org/10.1016/S0022-5347(17)71895-2
  6. McCormack LJ, Hazard JB, Poutasse EF. Obstructive lesions of the renal artery associated with remediable hypertension. Am J Pathol. 1958;34:582-582. 
  7. Plouin PF, Baguet JP, Thony F, Ormezzano O, Azarine A, Silhol F, Oppenheim C, Bouhanick B, Boyer L, Persu A. High prevalence of multiple arterial bed lesions in patients with fibromuscular dysplasia: The ARCADIA Registry (Assessment of Renal and Cervical Artery Dysplasia). Hypertension. 2017;70(3):652-658.  https://doi.org/10.1161/HYPERTENSIONAHA.117.09539
  8. Olin JW, Froehlich J, Gu X, Bacharach JM, Eagle K, Gray BH, Jaff MR, Mace P, Matsumoto AH, McBane RD, White CJ, Gornik HL. The United States Registry for Fibromuscular Dysplasia: Results in the first 447 patients. Circulation. 2012;125(25):3182-3190. https://doi.org/10.1161/CIRCULATIONAHA.112.091223
  9. Olin JW, Gornik HL, Bacharach JM, Biller J, Fine LJ, Gray BH, et al. Fibromuscular dysplasia: state of the science and critical unanswered questions: a scientific statement from the American Heart Association.Circulation. 2014;129(9):1048-1078. https://doi.org/10.1161/01.cir.0000442577.96802.8c
  10. Persu A, Giavarini A, Touzé E, Januszewicz A, Sapoval M, Azizi M, Barral X, Jeunemaitre X, Morganti A, Plouin PF, de Leeuw P; ESH Working Group Hypertension and the Kidney. European consensus on the diagnosis and management of fibromuscular dysplasia. J Hypertens. 2014;32(7):1367-1378. https://doi.org/10.1097/HJH.0000000000000213
  11. Schievink WI, Bjӧrnsson J. Fibromuscular dysplasia of the internal carotid artery: a clinicopathological study. Clin Neuropathol. 1996;15(1):2-6. 
  12. De Groote M, Van der Niepen P, Hemelsoet D, Callewaert B, Vermassen F, Billiouw JM, De Vriese A, Donck J, De Backer T. Fibromuscular dysplasia — results of amulticentre study in Flanders. Vasa. 2017;46(3):211-218.  https://doi.org/10.1024/0301-1526/a000613
  13. Touzé E, Oppenheim C, Trystram D, Nokam G, Pasquini M, Alamowitch S, Herve D, Garnier P, Mousseaux E, Plouin P-F. Fibromuscular dysplasia of cervical and intracranial arteries. Int J Stroke. 2010;5(4):296-305.  https://doi.org/10.1111/j.1747-4949.2010.00445.x
  14. Saw J, Aymong E, Sedlak T. Spontaneous coronary artery dissection: association with predisposing arteriopathies and precipitating stressors and cardiovascular outcomes. Circ Cardio vasc Interv. 2014;7(5):645-655.  https://doi.org/10.1161/CIRCINTERVENTIONS.114.001760
  15. Kim ESH, Olin JW, Froehlich JB, et al. Clinical manifestations of fibromuscular dysplasia vary by patient sex: A report of the U.S. Registry for FMD. J Am Coll Cardiol. 2013;62(21):2026-2028. https://doi.org/10.1016/j.jacc.2013.07.038
  16. Mettinger KL, Ericson K. Fibromuscular dysplasia and the brain. I. Observations on angiographic, clinical and genetic characteristics. Stroke. 1982;13(1):46-52.  https://doi.org/10.1161/01.str.13.1.46
  17. Gladstien K, Rushton AR, Kidd KK. Penetrance estimates and recurrence risks for fibromuscular dysplasia. Clin Genet. 1980;17:115-116.  https://doi.org/10.1111/j.1399-0004.1980.tb00117.x
  18. Rushton AR. The genetics of fibromuscular dysplasia. Arch Intern Med. 1980;140(2):233-236.  https://doi.org/10.1001/archinte.1980.00330140091024
  19. Perdu J, Boutouyrie P, Bourgain C. Inheritance of arterial lesions in renal fibromuscular dysplasia. J Hum Hypertens. 2007;21(5):393-400.  https://doi.org/10.1038/sj.jhh.1002156
  20. Southerland AM, Meschia JF, Worrall BB. Shared associations of nonatherosclerotic, large-vessel, cerebrovascular arteriopathies: considering intracranial aneurysms, cervical artery dissection, moyamoya disease and fibromuscular dysplasia. Curr Opin Neurol. 2013;26(1):13-28.  https://doi.org/10.1097/WCO.0b013e32835c607f
  21. Poloskey SL, Kim E, Sanghani R. Low yield of genetic testing for known vascular connective tissue disorders in patients with fibromuscular dysplasia. Vasc Med. 2012;17:371-378.  https://doi.org/10.1177/1358863X12459650
  22. Ganesh SK, Morissette R, Xu Z. Clinical and biochemical profiles suggest fibromuscular dysplasia is a systemic disease with altered TGF-β expression and connective tissue features. FASEB J. 2014;28:3313-3324. https://doi.org/10.1096/fj.14-251207
  23. Kiando SR, Barlassina C, Cusi D. Exome sequencing in seven families and gene-based association studies indicate genetic heterogeneity and suggest possible candidates for fibromuscular dysplasia. J Hypertens. 2015;33(9):1802-1810. https://doi.org/10.1097/HJH.0000000000000625
  24. Kiando SR, Tucker NR, Castro-Vega LJ. PHACTR1 is a genetic susceptibility locus for fibromuscular dysplasia supporting its complex genetic pattern of inheritance. PLoS Genet. 2016;12(10):10063-10067. https://doi.org/10.1371/journal.pgen.1006367
  25. Debette S, Kamatani Y, Metso TM, Kloss M. Common variation in PHACTR1 is associated with susceptibility to cervical artery dissection. Nat Genet. 2015;47(1):78-83.  https://doi.org/10.1038/ng.3154
  26. Gupta RM, Hadaya J, Trehan A, Zekavat SM, Roselli C, Klarin D, Emdin CA, Hilvering CRE, Bianchi V, Mueller C, Khera AV, Ryan RJH, Engreitz JM, Issner R, Shoresh N, Epstein CB, de Laat W, Brown JD, Schnabel RB, Bernstein BE, Kathiresan S. Agenetic variant associated with five vascular diseases is a distal regulator of endothelin-1 gene expression. Cell. 2017;170(3):522-533.  https://doi.org/10.1016/j.cell.2017.06.049
  27. Shimabukuro M. A new plausible link between lysophosphatidylcholine, TGF-β, and fibromuscular dysplasia. J Atheroscler Thromb. 2016;23(6):665-667.  https://doi.org/10.5551/jat.ED040
  28. O’Connor S, Kim ESh, Brinza E, Moran R, Fendrikova-Mahlay N, Wolski K, Gornik HL. Systemic connective tissue features in women with fibromuscular dysplasia. Vasc Med. 2015;20(5):454-462.  https://doi.org/10.1177/1358863X15592192
  29. Kalashnikova LA, Sakharova AV, Dobrynina LA, Mir-Kasimov MF, Chaikovskaia RP, Konovalov RN, Protskii SV, Shabalina AA, Kostyreva MV. Mitochondrial arteriopathy as a cause of spontaneous dissection of cerebral arteries. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2010;110(4-2):3-11. (In Russ.).
  30. Kalashnikova LA, Chaykovskaia RP, Dobrynina LA, Sakharova AV, Gulevskaya TS, Dreval MV, Ivanova MV. Internal carotid artery dissection as a cause of severe ischemic stroke with lethal outcome. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2015;115(12-2):19-25. (In Russ.). https://doi.org/10.17116/jnevro201511512219-25
  31. Kalashnikova LA, Dobrynina LA. Dissektsiya arterii golovnogo mozga: ishemicheskii insul't i drugie klinicheskie proyavleniya. Moscow: VAKO; 2013. (In Russ.).
  32. Gubanova MV, Kalashnikova LA, Dobrynina LA, Shamtieva KV, Berdalin AB. Markers of connective tissue dysplasia in cervical artery dissection and its predisposing factors. Annals of Clinical and Experimental Neurology. 2017;11(4):19-28. (In Russ.). https://doi.org/10.18454/ACEN.2017.4.2
  33. Savard S, Azarine A, Jeunemaitre X. Association of smoking with phenotype at diagnosis and vascular interventions in patients with renal artery fibromuscular dysplasia. Hypertension. 2013;61:1227-1232. https://doi.org/10.1161/HYPERTENSIONAHA.111.00838
  34. Silhol F, Sarlon-Bartoli G, Daniel L. Intranuclear expression of progesterone receptors in smooth muscle cells of renovascular fibromuscular dysplasia: A pilot study. Ann Vasc Surg. 2015;29(4):830-835.  https://doi.org/10.1016/j.avsg.2014.10.025
  35. Van der Nes JA, Bajanowski T, Trübner K. Fibromuscular dysplasia of the basilar artery: an unusual case with medicolegal implications. Forensic Sci Int. 2007;173(2-3):188-192.  https://doi.org/10.1016/j.forsciint.2007.02.016
  36. Belen D, Bolay H, Firat M, Akpinar G, Bertan V. Unusual appearance of intracranial fibromuscular dysplasia: a case report. Angiology. 1996;47(6):627-632.  https://doi.org/10.1177/000331979604700613
  37. Nakamura M, Rosahl SK, Vorkapic P, Fӧrster C, Samii M. De novo formation of an aneurysm in a case of unusual intracranial fibromuscular dysplasia. Clin Neurol Neurosurg. 2000;102(4):259-264.  https://doi.org/10.1016/S0303-8467(00)00114-1
  38. O’Connor SC, Poria N, Gornik HL. Fibromuscular dysplasia: an update for the headache clinician. Headache. 2015;55(5):748-755.  https://doi.org/10.1111/head.12560
  39. Kalashnikova LA, Dobrynina LA, Korepina OS, Gubanova MV, Timiraysova AA. Anamnestic headache in patients with cervical artery dissection: clinical characteristics and pathogenetic mechanisms. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2018;118(7):4-11. (In Russ.). https://doi.org/10.17116/jnevro2018118714
  40. Kalashnikova LA, Chaykovskaia RP, Gulevskaya TS, Dobrynina LA, Gubanova MV, Dreval MV, Maksimova MYu. Intimal rupture of the dysplastic middle cerebral artery wall complicated by thrombosis and fatal ischemic stroke. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2018;118(3-2):9-14. (In Russ.). https://doi.org/10.17116/jnevro2018118329-14
  41. Kalashnikova LA, Dobrynina LA, Dreval MV, Doronina EV, Nazarova MA. Neck pain and headache as the only manifestation of cervical artery dissection. Zhurnal Nevrologii i Psikhiatrii imeni. S.S. Korsakova. 2015;115(3):9-16. (In Russ.). https://doi.org/10.17116/jnevro2015115319-16
  42. Cloft HJ, Kallmes DF, Kallmes MH, Goldstein JH, Jensen ME, Dion JE. Prevalence of cerebral aneurysms in patients with fibromuscular dysplasia: a reassessment. J Neurosurg. 1998;88(3):436-440.  https://doi.org/10.3171/jns.1998.88.3.0436
  43. Etminan N, Brown RD Jr, Beseoglu K, Seppo Juvela S, Raymond J, Morita A, et al. The unruptured intracranial aneurysm treatment score: a multidisciplinary consensus. Neurology. 2015;85(10):881-889.  https://doi.org/10.1212/WNL.0000000000001891
  44. Joux J, Chausson N, Jeannin S. Carotid-bulba typical fibromuscular dysplasia in young Afro-Caribbean patients with stroke. Stroke. 2014;45(12):3711-3713. https://doi.org/10.1161/STROKEAHA.114.007313
  45. Kubis N, Von Langsdorff D, Petitjean C. Thrombotic carotid megabulb: fibromuscular dysplasia, septae and ischemic stroke. Neurology. 1999;52(4):883-886.  https://doi.org/10.1212/WNL.52.4.883
  46. Choi PM, Menon BK, Demchuk AM. Carotid web and stroke. Eur J Neurol. 2014;21(6):53.  https://doi.org/10.1111/ene.12418
  47. Choi PM, Singh D, Trivedi A. Carotid webs and recurrent ischemic strokes in the era of CT angiography. AJNR Am J Neuroradiol. 2015;36(11):2134-2139. https://doi.org/10.3174/ajnr.A4431
  48. Lenck S, Labeyrie MA, Saint-Maurice JP, Tarlov N, Houdart E. Diaphragms of the carotid and vertebral arteries: an under-diagnosed cause of ischaemic stroke. Eur J Neurol. 2014;21(4):586-593.  https://doi.org/10.1111/ene.12343
  49. Chaari D, Baud JM, Deschamps L. Carotid diaphragm: Atypical fibromuscular dysplasia or atheromatous lesions? Rev Neurol (Paris). 2017;173(4):230-233.  https://doi.org/10.1016/j.neurol.2017.03.012
  50. Ukkola-Pons E, Sadik JC, Champtiaux N. Free floating thrombus on carotid megabulb or suspended bulb: what kind of dysplasia? [in French]. Rev Neurol (Paris). 2012;168(1):53-56.  https://doi.org/10.1016/j.neurol.2011.03.009
  51. Haussen DC, Grossberg JA, Bouslama M. Carotid web (intimal fibromuscular dysplasia) has high stroke recurrence risk and is amenable to stenting. Stroke. 2017;48(11):3134-3137. https://doi.org/10.1161/STROKEAHA.117.019020
  52. Kirton A, Crone M, Benseler S. Fibromuscular dysplasia and childhood stroke. Brain. 2013;136(6):1846-1856. https://doi.org/10.1093/brain/awt111
  53. Green R, Gu X, Kline-Rogers E. Differences between the pediatric and adult presentation of fibromuscular dysplasia: results from the US Registry. Pediatr Nephrol. 2016;31(4):641-650.  https://doi.org/10.1007/s00467-015-3234-z
  54. Varennes L, Tahon F, Kastler A. Fibromuscular dysplasia: what the radiologist should know: a pictorial review. Insights Imaging. 2015;6(3):295-307.  https://doi.org/10.1007/s13244-015-0382-4
  55. Zhou W, Bush RL, Lin PL, Lumsden AB. Fibromuscular dysplasia of the carotid artery. J Am Coll Surg. 2005;200(5):807.  https://doi.org/10.1016/j.jamcollsurg.2004.09.051
  56. Arning C, Grzyska U. Color Doppler imaging of cervicocephalic fibromuscular dysplasia. Cardiovasc Ultrasound. 2004;2:7.  https://doi.org/10.1186/1476-7120-2-7
  57. Biller J, Sacco RL, Albuquerque FC; American Heart Association Stroke Council. Cervical arterial dissections and association with cervical manipulative therapy: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45(10):3155-3174. https://doi.org/10.1161/STR.0000000000000016
  58. Whelton PK, Carey RM, Aronow WS. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71(19):127-248.  https://doi.org/10.1016/j.jacc.2017.11.006
  59. Debette S, Metso T, Pezzini A. Cervical artery dissection and ischemic stroke patients (CADISP) Group. Association of vascular risk factors with cervical artery dissection and ischemic stroke in young adults. Circulation. 2011;123(14):1537-1544. https://doi.org/10.1161/CIRCULATIONAHA.110.000125
  60. Searchfield GD, Durai M, Linford TA. A state-of-the-art review: personalization of tinnitus sound therapy. Front Psychol. 2017;8:1599. https://doi.org/10.3389/fpsyg.2017.01599
  61. Etminan N, Rinkel GJ. Unruptured intracranial aneurysms: development, rupture and preventive management. Nat Rev Neurol. 2016;12(12):699-713.  https://doi.org/10.1038/nrneurol.2016.150
  62. Debette S. Pathophysiology and risk factors of cervical artery dissection: what have we learnt from large hospital-based cohorts? Curr Opin Neurol. 2014;27(1):20-28.  https://doi.org/10.1097/WCO.0000000000000056
  63. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J, Brown M, Demaerschalk BM Hoh B, Jauch EC, Kidwell CS, Leslie-Mazwi TM, Ovbiagele B, Scott PA, Sheth KN, Southerland AM, Summers DV, Tirschwell DL. American Heart Association Stroke Council. 2018 guidelines for the early management of patients with acute Ischemic stroke: a guideline for healthcare professionals from the American heart association/American stroke association. Stroke. 2018;49:e46–110.  https://doi.org/10.1161/STR.0000000000000158
  64. Rahme RJ, Aoun SG, McClendon JJr, El Ahmadieh TY, Bendok BR. Spontaneous cervical and cerebral arterial dissections: diagnosis and management. Neuroimaging Clin N Am. 2013;23(4):661-671.  https://doi.org/10.1016/j.nic.2013.03.013
  65. Schirmer CM, Atalay B, Malek AM. Endovascular recanalization of symptomatic flow-limiting cervical carotid dissection in an isolated hemisphere. Neurosurg Focus. 2011;30(6):16-16.  https://doi.org/10.3171/2011.2.FOCUS1139
  66. Larsson SC, King A, Madigan J, Levi C, Norris JW, Markus HS. Prognosis of carotid dissecting aneurysms: results from CADISS and a systematic review. Neurology. 2017;88(7):646-652.  https://doi.org/10.1212/WNL.0000000000003617
  67. Touzé E, Randoux B, Méary E, Arquizan C, Meder JF, Mas JL. Aneurysmal forms of cervical artery dissection: associated factors and outcome. Stroke. 2001;32(2):418-423.  https://doi.org/10.1161/01.STR.32.2.418
  68. Debette S, Compter A, Labeyrie MA. Epidemiology, pathophysiology, diagnosis, and management of intracranial artery dissection. Lancet Neurol. 2015;14(6):640-654.  https://doi.org/10.1016/S1474-4422(15)00009-5
  69. Hage ZA, Behbahani M, Amin-Hanjani S, Charbel FT. Carotid bypass for carotid occlusion. Curr Atheroscler Rep. 2015;17(7):36.  https://doi.org/10.1007/s11883-015-0517-6
  70. Pasquini M, Trystram D, Nokam G, Gobin-Metteil MP, Oppenheim C, Touzé E. Fibromuscular dysplasia of cervicocephalic arteries: prevalence of multisite involvement and prognosis. Rev Neurol (Paris). 2015;171(8-9):616-623.  https://doi.org/10.1016/j.neurol.2015.02.011
  71. Corrin LS, Sandok BA, Houser OW. Cerebral ischemic events in patients with carotid artery fibromuscular dysplasia. Arch Neurol. 1981;38(10):616-618.  https://doi.org/10.1001/archneur.1981.00510100044005
  72. Liu CH, Wu D, Chin SC. Cervicocranial fibromuscular dysplasia in Taiwanese ischemic stroke patients. Eur Neurol. 2012;67(3):129-135.  https://doi.org/10.1159/000331623
  73. Stewart MT, Moritz MW, Smith RB, Fulenwider JT, Perdue GD. The natural history of carotid fibromuscular dysplasia. J Vasc Surg. 1986;3(2):305-310.  https://doi.org/10.1016/0741-5214(86)90015-7
  74. Wells RP, Smith RR. Fibromuscular dysplasia of the internal carotid artery: a long term follow-up. Neurosurgery. 1982;10(1):39-43. 
  75. Wesen CA, Elliott BM. Fibromuscular dysplasia of the carotid arteries. Am J Surg. 1986;151(4):448-451.  https://doi.org/10.1016/0002-9610(86)90100-5
  76. Harriott AM, Zimmerman E, Singhal AB, Jaff MR, Lindsay ME, Rordorf GA. Cerebrovascular fibromuscular dysplasia: the MGH cohort and literature review. Neurol Clin Pract. 2017;7(3):225-236.  https://doi.org/10.1212/CPJ.0000000000000339
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.